Research Article
BibTex RIS Cite

Intralesional interferon alfa-2a therapy in adult hemangiomas

Year 1995, Volume: 8 Issue: 2, 67 - 72, 01.03.1995

Abstract

Hemangiomas, mostly appearing in infancy, generally involute completely and with their complications, rarely demand medical or surgical intervention. On the other hand, hemangiomas of adult life are persistant and usually no problems other than cosmetic ones accompany the lesions. So, appropriate methods, with no complications and side effects, must be preferred in the treatment. Most of the prior methods are usually inadequate in the management of the process.

Regression effect of systemic interferon treatment on infantile hemangiomas was perceived before. Similarly, we injected interferon alfa-2a into the adult hemangiomas three times a week, for three weeks and observed regression of the lesions by morphologic, histopathologic and ultrastructural evaluation.

References

  • Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Pediatr Scand 1955;44:370-379.
Year 1995, Volume: 8 Issue: 2, 67 - 72, 01.03.1995

Abstract

References

  • Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Pediatr Scand 1955;44:370-379.
There are 1 citations in total.

Details

Subjects Clinical Sciences
Journal Section Review Makaleler
Authors

N. Durak This is me

E. Kışlaoğlu This is me

F. Yüksel This is me

İ. Okar This is me

T. Şan This is me

Publication Date March 1, 1995
Published in Issue Year 1995 Volume: 8 Issue: 2

Cite

APA Durak, N., Kışlaoğlu, E., Yüksel, F., Okar, İ., et al. (1995). Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Medical Journal, 8(2), 67-72.
AMA Durak N, Kışlaoğlu E, Yüksel F, Okar İ, Şan T. Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Med J. March 1995;8(2):67-72.
Chicago Durak, N., E. Kışlaoğlu, F. Yüksel, İ. Okar, and T. Şan. “Intralesional Interferon Alfa-2a Therapy in Adult Hemangiomas”. Marmara Medical Journal 8, no. 2 (March 1995): 67-72.
EndNote Durak N, Kışlaoğlu E, Yüksel F, Okar İ, Şan T (March 1, 1995) Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Medical Journal 8 2 67–72.
IEEE N. Durak, E. Kışlaoğlu, F. Yüksel, İ. Okar, and T. Şan, “Intralesional interferon alfa-2a therapy in adult hemangiomas”, Marmara Med J, vol. 8, no. 2, pp. 67–72, 1995.
ISNAD Durak, N. et al. “Intralesional Interferon Alfa-2a Therapy in Adult Hemangiomas”. Marmara Medical Journal 8/2 (March 1995), 67-72.
JAMA Durak N, Kışlaoğlu E, Yüksel F, Okar İ, Şan T. Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Med J. 1995;8:67–72.
MLA Durak, N. et al. “Intralesional Interferon Alfa-2a Therapy in Adult Hemangiomas”. Marmara Medical Journal, vol. 8, no. 2, 1995, pp. 67-72.
Vancouver Durak N, Kışlaoğlu E, Yüksel F, Okar İ, Şan T. Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Med J. 1995;8(2):67-72.